YMI: got an email reply back from the vice president of the YMI regarding price action in the stock.
THIS IS WHAT HE HAD TO SAY.
Quote:
--------------------------------------------------------------------------------
We have no idea why our stock is under such a large amount of pressure lately and can only speculate as to the cause. Like yourself we find it very frustrating, particularly as nothing at all has changed at YM to cause this. We remain enthusiastic for the prospects of our lead drug CYT387, for which we will present updated data at the ASH conference on Dec 12.
Regards,
James
--------------------------------------------------------------------------------
James Smith, M.Sc.(Eng)
VP Corporate Communications
YM BioSciences Inc.
5045 Orbitor Drive
Building 11, Suite 400
Mississauga, Ontario L4W 4Y4
